Sensitive direct radio-immunoassay for human renin. 1984

T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa

A sensitive direct human renin radio-immunoassay has been developed for clinical use. The antigen source was human renal renin purified from Haas' preparation by pepstatin-C6-sepharose affinity chromatography, this was used to prepare a specific human renin antibody. The radio-immunoassay was performed by the double antibody technique using the delayed tracer addition method. Standard curves were obtained over the range 0.2-8.0 ng/ml. Dilution curves of human renal renin and human plasma were superimposable on the standard curve. Both active and inactive renin were detected by this method, and measurements correlated well with total renin activity after trypsin activation. Intra- and inter-assay coefficients of variance were 4.6% and 5.1%, respectively. Renin concentration was higher in patients with renovascular hypertension (1.97 +/- 0.38 ng/ml, mean +/- s.d., n = 10, P less than 0.01), but lower in primary aldosteronism (0.66 +/- 0.16 ng/ml, n = 13, P less than 0.01) compared with essential hypertension (1.38 +/- 0.34 ng/ml, n = 12). This method provides a new tool for the investigation of the renin-angiotensin system in man.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's

Related Publications

T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
April 1988, Scandinavian journal of clinical and laboratory investigation,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
October 1992, Clinical chemistry,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
January 1981, Journal of immunological methods,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
January 1980, The Netherlands journal of medicine,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
December 1970, The Journal of physiology,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
July 1970, The Journal of physiology,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
August 1974, The Indian journal of medical research,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
June 1979, Clinica chimica acta; international journal of clinical chemistry,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
April 1987, Journal of hypertension,
T Ogihara, and J Higaki, and N Imai, and Y Kumahara, and K Murakami, and K Mori, and H Ogawa
January 1972, The Journal of physiology,
Copied contents to your clipboard!